TY  - GEN
AU  - Kohn,Christine G
AU  - Zeichner,Simon B
AU  - Chen,Qiushi
AU  - Montero,Alberto J
AU  - Goldstein,Daniel A
AU  - Flowers,Christopher R
TI  - Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma
SN  - 1527-7755
PY  - 2017///0728
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carboplatin
KW  - Cell Cycle Checkpoints
KW  - Clinical Trials, Phase III as Topic
KW  - Cost-Benefit Analysis
KW  - Dacarbazine
KW  - Disease-Free Survival
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - economics
KW  - Health Care Costs
KW  - statistics & numerical data
KW  - Humans
KW  - Ipilimumab
KW  - Markov Chains
KW  - Melanoma
KW  - drug therapy
KW  - Models, Economic
KW  - Nivolumab
KW  - Paclitaxel
KW  - Proto-Oncogene Proteins B-raf
KW  - genetics
KW  - Quality-Adjusted Life Years
KW  - Randomized Controlled Trials as Topic
KW  - Survival Rate
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1200/JCO.2016.69.6336
ER  -